|
|
||||||||
1From the Wound Healing Research Unit, Institute of Ophthalmology, London, United Kingdom; the 2Institute for Wound Research, University of Florida, Gainesville, Florida; and the 3Department of Anatomy and Cell Biology, University of Miami, Miami, Florida.
PURPOSE. This study was undertaken to investigate the role of connective tissue growth factor (CTGF) in fibroblast-to-myofibroblast differentiation and fibroblast-mediated collagen matrix contraction in the presence of mechanical stress.
METHODS. An in vitro three-dimensional contraction model of human corneal-fibroblastseeded collagen lattices (FSCLs) in the presence of mechanical stress generated by attaching the lattices to the culture well was used to measure FSCL contraction. FSCLs were treated with CTGF; TGF-ß1; serum-free (SF) control medium; or TGF-ß1 plus antisense oligodeoxynucleotides to CTGF; TGF-ß1 plus scrambled-sequence oligodeoxynucleotide to CTGF; or TGF-ß antibody. Expression of
-smooth muscle actin (
-SMA) by fibroblasts in FSCLs was detected by immunostaining and confocal microscopy, whereas ELISA was used for the fibroblasts cultured on plastic. The conditioned media were analyzed by ELISA for CTGF production.
RESULTS. Exogenous CTGF stimulated significantly less collagen matrix contraction and myofibroblast differentiation than TGF-ß1, but similar to that stimulated by SF. TGF-ß1 stimulated fibroblasts to express CTGF. CTGF antisense oligodeoxynucleotide inhibited TGF-ß1stimulated myofibroblast differentiation and FSCL contraction. Exogenous CTGF circumvented the inhibitory effects of CTGF antisense on FSCL contraction. TGF-ß antibody significantly inhibited FSCL contraction and myofibroblast differentiation under mechanical stress and SF control conditions.
CONCLUSIONS. In the presence of mechanical stress, CTGF is necessary for TGF-ß1stimulation of myofibroblast differentiation and subsequent collagen matrix contraction, but CTGF alone is not sufficient to induce myofibroblast differentiation and collagen matrix contraction. Thus, TGF-ß1 appears to regulate multiple genes that are essential for fibroblast-mediated contraction of stressed matrix, one of which is CTGF.
This article has been cited by other articles:
![]() |
Y.-q. Xiao, K. Liu, J.-f. Shen, G.-T. Xu, and W. Ye SB-431542 Inhibition of Scar Formation after Filtration Surgery and Its Potential Mechanism Invest. Ophthalmol. Vis. Sci., April 1, 2009; 50(4): 1698 - 1706. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Meyer-ter-Vehn, B. Katzenberger, H. Han, F. Grehn, and G. Schlunck Lovastatin Inhibits TGF-{beta}-Induced Myofibroblast Transdifferentiation in Human Tenon Fibroblasts Invest. Ophthalmol. Vis. Sci., September 1, 2008; 49(9): 3955 - 3960. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Dawes, J. A. Eldred, I. K. Anderson, M. Sleeman, J. R. Reddan, G. Duncan, and I. M. Wormstone TGF{beta}-Induced Contraction Is Not Promoted by Fibronectin-Fibronectin Receptor Interaction, or {alpha}SMA Expression Invest. Ophthalmol. Vis. Sci., February 1, 2008; 49(2): 650 - 661. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Lehti, M. Silvennoinen, R. Kivela, H. Kainulainen, and J. Komulainen Effects of streptozotocin-induced diabetes and physical training on gene expression of extracellular matrix proteins in mouse skeletal muscle Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E900 - E907. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Meyer-ter-Vehn, S. Gebhardt, W. Sebald, M. Buttmann, F. Grehn, G. Schlunck, and P. Knaus p38 Inhibitors Prevent TGF-{beta}-Induced Myofibroblast Transdifferentiation in Human Tenon Fibroblasts. Invest. Ophthalmol. Vis. Sci., April 1, 2006; 47(4): 1500 - 1509. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C.J. Howell, R. H. Johns, J. A. Lasky, B. Shan, C. J. Scotton, G. J. Laurent, and R. C. Chambers Absence of Proteinase-Activated Receptor-1 Signaling Affords Protection from Bleomycin-Induced Lung Inflammation and Fibrosis Am. J. Pathol., May 1, 2005; 166(5): 1353 - 1365. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Saika, T. Miyamoto, O. Yamanaka, T. Kato, Y. Ohnishi, K. C. Flanders, K. Ikeda, Y. Nakajima, W. W.-Y. Kao, M. Sato, et al. Therapeutic Effect of Topical Administration of SN50, an Inhibitor of Nuclear Factor-{kappa}B, in Treatment of Corneal Alkali Burns in Mice Am. J. Pathol., May 1, 2005; 166(5): 1393 - 1403. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Matsuda, F. Gomi, Y. Oshima, M. Tohyama, and Y. Tano Vascular Endothelial Growth Factor Reduced and Connective Tissue Growth Factor Induced by Triamcinolone in ARPE19 Cells under Oxidative Stress Invest. Ophthalmol. Vis. Sci., March 1, 2005; 46(3): 1062 - 1068. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Higgins, M. P. Biju, Y. Akai, A. Wutz, R. S. Johnson, and V. H. Haase Hypoxic induction of Ctgf is directly mediated by Hif-1 Am J Physiol Renal Physiol, December 1, 2004; 287(6): F1223 - F1232. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |